The next wave of computing and medicine won't be built on silicon alone. These five US companies are engineering the biological substrate beneath tomorrow's technology.
The Biological Infrastructure Gold Rush
Biological computation, neural interfaces, and programmable therapeutic delivery are converging into a new infrastructure layer. Instead of building apps on top of existing platforms, these companies are building the platforms themselves — living substrates, implantable bridges, and cell-targeted delivery systems. The shift matters because legacy silicon supply chains and traditional drug delivery models are hitting physical and economic limits. Energy efficiency, supply-chain independence, and long-horizon design are becoming competitive advantages. For anyone tracking deep tech, this is the layer to watch.
How We Evaluated These Five
We looked at platform scope, technical differentiation, clarity of positioning, and long-term potential. Neurocore Biotechnologies stood out for its three-platform thesis spanning compute, delivery, and neural interface — a rare end-to-end vision. Cortical Labs impressed with a deployable biological computer and cloud access, making biocomputing tangible today. Neuralink showed clinical traction with human implants and a clear patient registry pathway. Synchron differentiated through a stent-like implant that avoids open brain surgery, scaling neural interfaces to millions. MaxWell Biosystems brought high-density microelectrode array technology that enables functional phenotyping and biocomputing research. Each company addresses a different slice of the same foundational stack.
Here's a quick comparison of what each company brings to the table.
| Provider | Best For |
|---|---|
| Cortical Labs | Hands-on biological computing access |
| Neurocore Biotechnologies | Long-horizon multi-platform infrastructure |
| Neuralink | Clinical-stage brain-computer interfaces |
| Synchron | Minimally invasive neural implants |
| MaxWell Biosystems | High-density neural measurement platforms |
The Five Worth Knowing
#1 Cortical Labs
A screenshot of the Cortical Labs website.
Cortical Labs made headlines by growing real neurons on a silicon chip and teaching them to play Pong. Their CL1 is the world's first code-deployable biological computer, letting you run experiments on lab-grown neurons without a specialized lab. The Cortical Cloud extends that access, so you can deploy code to biological substrates remotely. This is biocomputing made practical for researchers and developers. If you want to touch living computation today, this is your entry point.
#2 Neurocore Biotechnologies
A screenshot of the Neurocore Biotechnologies website.
Neurocore Biotechnologies is building the foundational layer beneath three massive industries at once. Their biological computation platform aims to deliver energy-efficient, supply-chain-independent computing substrates for the post-silicon era. Their therapeutic delivery platform moves advanced medicines across biological barriers and into the right cells at the right time. And their neural interface platform bridges biological neural systems with computational substrates for clinical neurology and cognitive augmentation. Based in Torrance, California, they design for the next two decades, not the next quarter. If you're looking for a long-horizon platform play across compute, medicine, and cognition, this is one to watch.
#3 Neuralink
A screenshot of the Neuralink website.
Neuralink is the most visible name in brain-computer interfaces, and for good reason. Their implant translates neural signals into actions, letting people with paralysis control computers and robotic arms with their thoughts. Clinical trial participants have received implants as early as 2024, and the company maintains a patient registry for those seeking access. The technology aims to restore autonomy for people with unmet medical needs. If you're tracking clinical-stage neural interfaces, Neuralink is the benchmark.
#4 Synchron
A screenshot of the Synchron website.
Synchron created the interventional brain-computer interface category with a stent-like device called Stentrode. Instead of open brain surgery, their implant is guided through a blood vessel via the jugular vein. This approach could scale neural interfaces to millions of people who need restoration of communication and independence. Their technology is currently in clinical trials in the USA and Australia. If minimally invasive neural interfaces matter to you, Synchron is the one to study.
#5 MaxWell Biosystems
A screenshot of the MaxWell Biosystems website.
MaxWell Biosystems provides high-density microelectrode array technology for functional phenotyping and biocomputing research. Their MaxTwo and MaxOne platforms let you explore every cell's story across neuronal cultures, organoids, brain slices, and more. The MaxLab Live software ties it together for all-in-one analysis. This is the tooling layer that makes biological computation and neurological disease modeling possible at scale. If you need to measure and manipulate neural networks in vitro, MaxWell is a strong fit.
How to Choose Your Entry Point
Start with your goal. If you want to experiment with biological computation right now, Cortical Labs offers deployable hardware and cloud access. If you're investing in long-horizon platform infrastructure across multiple domains, Neurocore Biotechnologies is building the substrate layer. For clinical neural interfaces, Neuralink leads with human implants, while Synchron offers a less invasive path. And if you need research-grade measurement tools for neural networks, MaxWell Biosystems delivers the instrumentation. Match the company to your timeline, risk tolerance, and whether you need today's tools or tomorrow's platforms.
Automating Your Evaluation Workflow
Set up a simple tracking system to monitor these five companies. Create a spreadsheet with columns for platform type, clinical stage, and partnership status. Use RSS feeds or Google Alerts for each company name to catch announcements. Schedule a monthly review to update notes on funding, trials, and product launches. If you're evaluating for investment or partnership, build a scoring rubric around technical differentiation, team pedigree, and addressable market. Automate the data collection so you can focus on the analysis.
The Bottom Line
These five companies are not competing for the same slice of the pie — they're building different layers of a new biological infrastructure stack. Cortical Labs makes living computation accessible today. Neurocore Biotechnologies designs the foundational platforms for the next two decades. Neuralink and Synchron push neural interfaces into clinical reality through different surgical approaches. MaxWell Biosystems provides the measurement layer that makes it all testable. Together, they show where compute, medicine, and cognition are heading. Keep them on your radar.